This inventor holds 8 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: Wake Forest University, Johns Hopkins University. Active years: 2009-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
8 out of 525 
1 out of 3,806 
Years Active: 2009-2022
Title: Innovations by Jianfeng Xu: Pioneering Genetic Research
Introduction
Jianfeng Xu, a notable inventor based in Clemmons, North Carolina, holds a significant portfolio of 8 patents. His innovative work primarily focuses on the assessment of genetic markers associated with prostate cancer risk, contributing vital advancements in cancer research and screening methodologies.
Latest Patents
Jianfeng Xu’s latest invention revolves around methods and compositions for correlating genetic markers with prostate cancer risk. This groundbreaking approach involves analyzing nucleic acid samples from individuals to determine their genotypes at various biallelic polymorphic loci. By calculating a cumulative relative risk (CRR) based on the determined genotype, the method identifies individuals at an increased risk of developing prostate cancer. A CRR greater than 1.00 indicates a higher risk, categorizing subjects suitable for early PSA screening, prostate biopsies, or chemoprevention, ultimately enhancing patient care and preventive strategies in oncology.
Career Highlights
Throughout his career, Jianfeng Xu has contributed his expertise to reputable institutions, including Wake Forest University and The Johns Hopkins University. His affiliations with these esteemed organizations underscore his commitment to advancing medical research and developing innovative healthcare solutions.
Collaborations
Jianfeng Xu has worked alongside talented colleagues such as Siqun Lilly Zheng and Jielin Sun, fostering a collaborative environment that encourages knowledge sharing and drives the development of pioneering research projects. These partnerships have been instrumental in the successful advancement of his inventions and their applications in clinical settings.
Conclusion
Jianfeng Xu’s innovative contributions to the field of genetic research demonstrate his dedication to improving cancer risk assessment methods. Through his patents, he not only advances scientific knowledge but also enhances the potential for early detection and preventive treatment of prostate cancer, positively impacting the lives of many.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile